Michael Bloom, Associate Professor, Global and Community Health, received $158,900 from the National Institutes of Health for the project: “Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program.”
Roche test for accelerating Alzheimer’s diagnosis granted FDA clearance
Dive Brief: Roche received 510(k) clearance for a test that could help cut the time it takes to diagnose Alzheimer’s disease. Currently, physicians diagnose Alzheimer’s by
June 30, 2023